✦ LIBER ✦

Long term follow-up of BEAM-autologous and BEAM-alemtuzumab allogeneic stem cell transplantation in relapsed advanced stage follicular lymphoma

✍ Scribed by Noriega, Victor; Kaur, Harpreet; Devereux, Stephen; Byrne, Jennifer; Marcus, Robert; Haynes, Andrew; Yallop, Deborah; McMillan, Andrew; Ingram, Wendy; Khan, Anjum; Kenyon, Michelle; Potter, Victoria; Russell, Nigel; Mufti, Ghulam J.; Pagliuca, Antonio

Book ID: 122313167
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 1011 KB
Volume: 38
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2014.03.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of BEAM-autologous and BEAM-alem

Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma

✍ Wendy Ingram; Stephen Devereux; Emma P. Das-Gupta; Nigel H. Russell; Andrew P. H 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

Long-term follow-up of autologous stem-c

Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma

✍ Åke Berglund; Gunilla Enblad; Kristina Carlson; Bengt Glimelius; Hans Hagberg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Long-term follow-up of reduced-intensity

Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma

✍ Yukako Ono; Takehiko Mori; Jun Kato; Akiko Yamane; Takayuki Shimizu; Taku Kikuch 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Myeloablative allogeneic stem cell trans

Myeloablative allogeneic stem cell transplantation for advanced stage multiple myeloma: very long-term follow up of a single center experience

✍ G. A. KENNEDY; J. BUTLER; J. MORTON; G. HILL; R. WESTERN; J. CUMMINGS; R. ALLISO 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Reduced-intensity conditioning for allog

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes

✍ Karl S. Peggs; Anna Sureda; Wendi Qian; Dolores Caballero; Ann Hunter; Alvaro Ur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Prognostic factors and long-term outcome

Prognostic factors and long-term outcome of autologous haematopoietic stem cell transplantation following a uniform-modified BEAM-conditioning regimen for patients with refractory or relapsed Hodgkin lymphoma: a single-center experience

✍ Anna Czyz, Anna Lojko-Dankowska, Dominik Dytfeld, Adam Nowicki… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 315 KB